371 related articles for article (PubMed ID: 7973658)
21. Activation of the interleukin 2 receptor: a possible role for tyrosine phosphatases.
Ellery JM; Kempshall SJ; Nicholls PJ
Cell Signal; 2000 Jun; 12(6):367-73. PubMed ID: 10889465
[TBL] [Abstract][Full Text] [Related]
22. Interleukin-2 receptor gamma chain: a functional component of the interleukin-7 receptor.
Noguchi M; Nakamura Y; Russell SM; Ziegler SF; Tsang M; Cao X; Leonard WJ
Science; 1993 Dec; 262(5141):1877-80. PubMed ID: 8266077
[TBL] [Abstract][Full Text] [Related]
23. Activation of Stat5 by interleukin 2 requires a carboxyl-terminal region of the interleukin 2 receptor beta chain but is not essential for the proliferative signal transmission.
Fujii H; Nakagawa Y; Schindler U; Kawahara A; Mori H; Gouilleux F; Groner B; Ihle JN; Minami Y; Miyazaki T
Proc Natl Acad Sci U S A; 1995 Jun; 92(12):5482-6. PubMed ID: 7777534
[TBL] [Abstract][Full Text] [Related]
24. Monocyte function in a severe combined immunodeficient patient with a donor splice site mutation in the Jak3 gene.
Villa A; Sironi M; Macchi P; Matteucci C; Notarangelo LD; Vezzoni P; Mantovani A
Blood; 1996 Aug; 88(3):817-23. PubMed ID: 8704236
[TBL] [Abstract][Full Text] [Related]
25. Convergence of signaling transduced by prolactin (PRL)/cytokine chimeric receptors on PRL-responsive gene transcription.
Ferrag F; Chiarenza A; Goffin V; Kelly PA
Mol Endocrinol; 1996 Apr; 10(4):451-60. PubMed ID: 8721989
[TBL] [Abstract][Full Text] [Related]
26. Activation of JAK3, but not JAK1, is critical to interleukin-4 (IL4) stimulated proliferation and requires a membrane-proximal region of IL4 receptor alpha.
Malabarba MG; Kirken RA; Rui H; Koettnitz K; Kawamura M; O'Shea JJ; Kalthoff FS; Farrar WL
J Biol Chem; 1995 Apr; 270(16):9630-7. PubMed ID: 7721895
[TBL] [Abstract][Full Text] [Related]
27. Critical role of the membrane-proximal, proline-rich motif of the interleukin-2 receptor gammac chain in the Jak3-independent signal transduction.
Tsujino S; Miyazaki T; Kawahara A; Maeda M; Taniguchi T; Fujii H
Genes Cells; 1999 Jun; 4(6):363-73. PubMed ID: 10421845
[TBL] [Abstract][Full Text] [Related]
28. In vitro correction of JAK3-deficient severe combined immunodeficiency by retroviral-mediated gene transduction.
Candotti F; Oakes SA; Johnston JA; Notarangelo LD; O'Shea JJ; Blaese RM
J Exp Med; 1996 Jun; 183(6):2687-92. PubMed ID: 8676091
[TBL] [Abstract][Full Text] [Related]
29. Unexpected and variable phenotypes in a family with JAK3 deficiency.
Frucht DM; Gadina M; Jagadeesh GJ; Aksentijevich I; Takada K; Bleesing JJ; Nelson J; Muul LM; Perham G; Morgan G; Gerritsen EJ; Schumacher RF; Mella P; Veys PA; Fleisher TA; Kaminski ER; Notarangelo LD; O'Shea JJ; Candotti F
Genes Immun; 2001 Dec; 2(8):422-32. PubMed ID: 11781709
[TBL] [Abstract][Full Text] [Related]
30. Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans.
Noguchi M; Yi H; Rosenblatt HM; Filipovich AH; Adelstein S; Modi WS; McBride OW; Leonard WJ
Cell; 1993 Apr; 73(1):147-57. PubMed ID: 8462096
[TBL] [Abstract][Full Text] [Related]
31. IL-2 signaling involves recruitment and activation of multiple protein tyrosine kinases by the IL-2 receptor.
Taniguchi T; Miyazaki T; Minami Y; Kawahara A; Fujii H; Nakagawa Y; Hatakeyama M; Liu ZJ
Ann N Y Acad Sci; 1995 Sep; 766():235-44. PubMed ID: 7486666
[TBL] [Abstract][Full Text] [Related]
32. Human lung myofibroblasts as effectors of the inflammatory process: the common receptor gamma chain is induced by Th2 cytokines, and CD40 ligand is induced by lipopolysaccharide, thrombin and TNF-alpha.
Doucet C; Giron-Michel J; Canonica GW; Azzarone B
Eur J Immunol; 2002 Sep; 32(9):2437-49. PubMed ID: 12207328
[TBL] [Abstract][Full Text] [Related]
33. Interleukin 12 (IL-12) induces tyrosine phosphorylation of JAK2 and TYK2: differential use of Janus family tyrosine kinases by IL-2 and IL-12.
Bacon CM; McVicar DW; Ortaldo JR; Rees RC; O'Shea JJ; Johnston JA
J Exp Med; 1995 Jan; 181(1):399-404. PubMed ID: 7528775
[TBL] [Abstract][Full Text] [Related]
34. Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome.
Zhang Q; Nowak I; Vonderheid EC; Rook AH; Kadin ME; Nowell PC; Shaw LM; Wasik MA
Proc Natl Acad Sci U S A; 1996 Aug; 93(17):9148-53. PubMed ID: 8799169
[TBL] [Abstract][Full Text] [Related]
35. Rapid protein-based assays for the diagnosis of T-B+ severe combined immunodeficiency.
Gilmour KC; Cranston T; Loughlin S; Gwyther J; Lester T; Espanol T; Hernandez M; Savoldi G; Davies EG; Abinun M; Kinnon C; Jones A; Gaspar HB
Br J Haematol; 2001 Mar; 112(3):671-6. PubMed ID: 11260071
[TBL] [Abstract][Full Text] [Related]
36. Impaired IL-7 signaling may explain a case of atypical JAK3-SCID.
Li J; Nara H; Rahman M; Juliana FM; Araki A; Asao H
Cytokine; 2010 Feb; 49(2):221-8. PubMed ID: 19889552
[TBL] [Abstract][Full Text] [Related]
37. Tumor-induced suppression of T lymphocyte proliferation coincides with inhibition of Jak3 expression and IL-2 receptor signaling: role of soluble products from human renal cell carcinomas.
Kolenko V; Wang Q; Riedy MC; O'Shea J; Ritz J; Cathcart MK; Rayman P; Tubbs R; Edinger M; Novick A; Bukowski R; Finke J
J Immunol; 1997 Sep; 159(6):3057-67. PubMed ID: 9300731
[TBL] [Abstract][Full Text] [Related]
38. Jeg-3 human choriocarcinoma-induced immunosuppression: downregulation of interleukin-2, interleukin-2 receptor alpha-chain, and its Jak/Stat signaling pathway.
Kilic M; Flossmann E; Flossmann O; Vogelsang H; Junker U; Chaouat G; Markert UR
Am J Reprod Immunol; 1999 Jan; 41(1):61-9. PubMed ID: 10097788
[TBL] [Abstract][Full Text] [Related]
39. Sharing of a common gamma chain, gamma c, by the IL-2, IL-4, and IL-7 receptors: implications for X-linked severe combined immunodeficiency (XSCID).
Leonard WJ; Noguchi M; Russell SM
Adv Exp Med Biol; 1994; 365():225-32. PubMed ID: 7887307
[No Abstract] [Full Text] [Related]
40. A novel mutant gammac chain from a patient with typical phenotype of X-linked severe combined immunodeficiency (SCID) has partial signalling function for mediating IL-2 and IL-4 receptor action.
Kumaki S; Ochs HD; Kuropatwinski KK; Konno T; Timour MS; Cosman D; Baumann H
Clin Exp Immunol; 1999 Feb; 115(2):356-61. PubMed ID: 9933465
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
